D. V. D. van den Wollenberg
发表
S. H. van der Burg,
D. Mustafa,
T. van Hall,
2020,
Journal for ImmunoTherapy of Cancer.
I. B. Borel Rinkes,
S. Shirasawa,
T. Sasazuki,
2006,
Cancer research.
P. Boulanger,
Saw-See Hong,
R. Hoeben,
2017,
Scientific Reports.
R. D. de Groot,
R. Hoeben,
S. Cramer,
2012,
PloS one.
S. H. van der Burg,
T. van Hall,
M. Sluijter,
2022,
Journal for ImmunoTherapy of Cancer.
A. van der Eb,
E. Briët,
R. Hoeben,
1995,
Blood.
A. van der Eb,
R. Hoeben,
H. van Ormondt,
1994,
Gene.
T. van Hall,
R. Hoeben,
M. Camps,
2018,
Cancer Gene Therapy.
A. van der Eb,
J. Alex,
E. Briët,
1996,
Molecular and cellular biology.
A. van der Eb,
A. Bout,
K. Hehir,
1998,
Human gene therapy.
D. Roy,
J. Bell,
S. Workenhe,
2019,
Scientific Reports.
M. Coffey,
A. Melcher,
R. Vile,
2018,
Cancer Immunology Research.
R. Hoeben,
R. Limpens,
V. Kemp,
2017,
Viruses.
Jort Vellinga,
Diana J M van den Wollenberg,
Martijn J W E Rabelink,
2004,
Journal of Virology.
M. Rabelink,
R. Hoeben,
V. Kemp,
2023,
International journal of molecular sciences.
P. C. van der Vliet,
R. D. de Jong,
R. Hoeben,
2006,
The Journal of general virology.
M. Lamfers,
M. Hornsveld,
G. van der Pluijm,
2021,
Human gene therapy.
M. Rabelink,
R. Hoeben,
D. V. D. van den Wollenberg,
2023,
Viruses.
P. Boulanger,
Saw-See Hong,
R. Hoeben,
2017,
Scientific Reports.
R. Hoeben,
V. Kemp,
D. V. D. van den Wollenberg,
2015,
Viruses.
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy
S. H. van der Burg,
P. ten Dijke,
T. van Hall,
2023,
Cancer research communications.
J. Schalken,
W. Karthaus,
C. D. de Ridder,
2021,
Cancer gene therapy.
O. Kranenburg,
I. B. Rinkes,
N. Smakman,
2005,
Journal of Virology.
D. Roy,
J. Bell,
S. Workenhe,
2019,
Scientific Reports.
Jort Vellinga,
Diana J M van den Wollenberg,
Stephanie van der Heijdt,
2005,
Journal of Virology.
R. Hoeben,
S. Cramer,
V. Kemp,
2018,
Gene Therapy.
M. Coffey,
A. Melcher,
R. Vile,
2018,
Cancer Immunology Research.
R. Hoeben,
S. Cramer,
V. Kemp,
2018,
Gene Therapy.